Edifice Health is a immunological health and personalized nutrition company offering a novel metric of inflammatory health.
Edifice Health is a spin-out company from a 10-year research study on immune profiling from Stanford University, the Stanford 1,000 Immunomes Project. The technology is the first biomarker composite scoring system to measure immune health and the Inflammatory Age® of an individual which predicts the onset of multiple chronic diseases and provides comprehensive health insights designed to help people change the course of their aging process.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 22, 2021 | Series Unknown | $12M | 1 | Leaps by Bayer | — | Detail |
Jan 1, 2019 | Seed | $1.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Leaps by Bayer | Yes | Series Unknown |
Better Food Ventures | — | Seed |